Insight does not come at random: Individual gray matter networks relate to clinical and cognitive insight in schizophrenia-Reference-Cited by-同舟云学术

Insight does not come at random: Individual gray matter networks relate to clinical and cognitive insight in schizophrenia

Published:2021-07 Issue: Volume:109 Page:110251
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Larabi Daouia I.,Marsman Jan-Bernard C.,Aleman André,Tijms Betty M.,Opmeer Esther M.,Pijnenborg Gerdina H.M.,van der Meer Lisette,van Tol Marie-José,Ćurčić-Blake Branislava

Funder

European Science Foundation

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference80 articles.

1. The convergence of maturational change and structural covariance in human cortical networks;Alexander-Bloch;J. Neurosci.,2013

2. DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders 4th edition TR;American Psychiatric Association,2000

3. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs;Andreasen;Biol. Psychiatry,2010

4. Hierarchical organization of human cortical networks in health and schizophrenia;Bassett;J. Neurosci.,2008

5. A new instrument for measuring insight: the Beck Cognitive Insight Scale;Beck;Schizophr. Res.,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three autism subtypes based on single‐subject gray matter network revealed by semi‐supervised machine learning;Autism Research;2024-06-24

2. Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials;Psychiatry Research;2024-04

3. Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial;BMC Psychiatry;2022-08-28

4. Risk factors for readmission in schizophrenia treated with combined psychoeducation and standard therapy;Neuropsychopharmacology Reports;2022-01-26